QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Distributed Multi-Dimensional Pricing for Efficient Application Offloading in Mobile Cloud Computing 期刊论文 IEEE TRANSACTIONS ON SERVICES COMPUTING, 2019, 卷号: 12, 期号: 6, 页码: 925-940 作者:  Xie, Kun;  Wang, Xin;  Xie, Gaogang;  Xie, Dongliang;  Cao, Jiannong 收藏  |  浏览/下载：9/0  |  提交时间：2020/12/10 Cloud computing  Mobile communication  Resource management  Pricing  Mobile handsets  Games  Servers  Mobile cloud  two-side market game  cloud offloading  cloudlet   Fine-Grained Vehicle Classification With Channel Max Pooling Modified CNNs 期刊论文 IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY, 2019, 卷号: 68, 期号: 4, 页码: 3224-3233 作者:  Ma, Zhanyu;  Chang, Dongliang;  Xie, Jiyang;  Ding, Yifeng;  Wen, Shaoguo 收藏  |  浏览/下载：4/0  |  提交时间：2019/11/15 Fine-grained  vehicle classification  convolutional neural network  channel pooling  feature extraction   Fine-Grained Vehicle Classification with Channel Max Pooling Modified CNNs 期刊论文 IEEE Transactions on Vehicular Technology, 2019, 卷号: 68, 期号: 4, 页码: 3224-3233 作者:  Ma, Zhanyu;  Chang, Dongliang;  Xie, Jiyang;  Ding, Yifeng;  Wen, Shaoguo 收藏  |  浏览/下载：14/0  |  提交时间：2020/11/14 Backpropagation algorithms  Convolution  Feature extraction  Motivation  Neural networks  Vehicles  channel pooling  Classification accuracy  Competitive performance  Convolutional neural network  Discriminative features  Fine grained  State-of-the-art methods  Vehicle classification   All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文 JOURNAL OF HEPATOLOGY, 2019, 卷号: 70 作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun 收藏  |  浏览/下载：57/0  |  提交时间：2019/12/05 All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang 收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05 Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China 期刊论文 BMC GASTROENTEROLOGY, 2019, 卷号: 19 作者:  Sun, Jian;  Ding, Huiguo;  Chen, Guofeng;  Wang, Guiqiang;  Wei, Lai 收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05 Chronic hepatitis B  Peg-interferon  Long-term follow-up  Sustained serological response  Sustained combined clinical response   THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang 收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05 All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang 收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05 THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05 All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05